Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group

Article ID	Journal	Published Year	Pages	File Type
8453277	Leukemia Research	2018	19 Pages	PDF

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research

Preview

Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group

Authors

Sotirios G. Papageorgiou, Ioannis Kotsianidis, Christos K. Kontos, Argyris Symeonidis, Athanasios Galanopoulos, Eleftheria Hatzimichael, Elias Poulakidas, Panagiotis Diamantopoulos, Theodoros P. Vassilakopoulos, Panagiotis Zikos, Helen Papadaki,